LoginRegister

    Shilpa Medicare gets EIR from USFDA for Jadcherla facility

    Written by Ruby Khatun Khatun   |  
    Shilpa Medicare gets EIR from USFDA for Jadcherla facility

    New Delhi: Shilpa Medicare on Saturday said the USFDA has issued an Establishment Inspection Report (EIR) for its Jadcherla facility in Telangana.


    The US health regulator has issued an EIR for the company's generic pharmaceutical manufacturing facility at Jadcherla, which was inspected between July 24-28, 2017, Shilpa Medicare said in a filing to BSE.


    The inspection has now been closed by the USFDA, it added.


    "The company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines in response to the form 483 issued at the end of the inspection," it said.


    The USFDA has reviewed the CAPA and found it acceptable, it added.

    CAPACorrective and Preventive ActionEIREstablishment Inspection Reportgenericindian pharma newsinspectionJadcherla facilitypharma newspharma news indiapharmaceutical manufacturing facilityShilpa MedicareUSFDA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X